Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 2

3(42.9%)

Phase 1

1(14.3%)

7Total

N/A(3)

Phase 2(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03287375Phase 2Completed

Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -

Role: lead

NCT03280511Phase 2Recruiting

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients

Role: lead

NCT04047004Phase 1Completed

Adjuvant PIPAC in Gastric Cancer Patients

Role: lead

NCT02320448Phase 2Completed

Treating Peritoneal Carcinomatosis With PIPAC

Role: lead

NCT02646462Unknown

Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer

Role: lead

NCT02260128Not ApplicableUnknown

Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer Surgery

Role: lead

NCT02209415Not ApplicableUnknown

EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer

Role: lead

NCT01044511Not ApplicableUnknown

Quality of Life With Esophageal Stent Trial

Role: lead

All 8 trials loaded